Year All2024202320222021 Aug 26, 2024 Eliem Therapeutics Announces Additions to its Leadership Team Aug 14, 2024 Eliem Therapeutics Reports Second Quarter Financial Results Jun 28, 2024 Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes Jun 27, 2024 Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement Apr 11, 2024 Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement